# Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

> **NCT07286058** · PHASE3 · RECRUITING · sponsor: **Takeda** · enrollment: 1182 (estimated)

## Conditions studied

- Psoriatic Arthritis

## Interventions

- **DRUG:** Zasocitinib

## Key facts

- **NCT ID:** NCT07286058
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-11
- **Primary completion:** 2029-12-18
- **Final completion:** 2029-12-18
- **Target enrollment:** 1182 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07286058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07286058, "Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07286058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*